When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. What Doctors Want Those Over 65 to Know About Getting the ...

   www.aol.com/doctors-want-those-over-65-113000100...

   The COVID-19 vaccine’s protection usually lasts four to six months, which isn’t enough for people who are vulnerable to serious complications from the virus, Dr. Russo says. “That’s also ...

3. List of COVID-19 vaccine authorizations - Wikipedia

   en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

   National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...

4. COVID-19 vaccination in the United States - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in...

   The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.

5. New COVID vaccines are here. What to know about latest ... - AOL

   www.aol.com/finance/covid-vaccines-know-latest...

   On the heels of the nation’s biggest summer COVID surge—test positivity peaked at 17.8% the week ended Aug. 10—help has arrived.The 2024–25 coronavirus vaccines, initially anticipated this ...

6. COVAX - Wikipedia

   en.wikipedia.org/wiki/COVAX

   COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF.

7. Soberana 02 - Wikipedia

   en.wikipedia.org/wiki/Soberana_02

   Soberana 02 or Soberana 2, technical name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac (Persian: پاستوکووک) in Iran, where it has been developed in collaboration with the Pasteur Institute of Iran. [2] [3] [4]